Last reviewed · How we verify
NCT03453073
Chocolate and CVD Risk in Postmenopausal Women
trial testing chocolate consumption level in Cardiovascular Disease in 83,310 participants. Completed in 1 July 2018.
30 April 2018
Quick facts
| Lead sponsor | Brooklyn College of the City University of New York |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 83,310 |
| Start date | 15 December 2014 |
| Primary completion | 30 April 2018 |
| Estimated completion | 1 July 2018 |
Drugs / interventions tested
- chocolate consumption level
- physician diagnosis of first occurrence of serious chronic disease
Conditions studied
- Cardiovascular Disease — all drugs for Cardiovascular Disease →
- Heart Disease — all drugs for Heart Disease →
- Stroke — all drugs for Stroke →
Sponsor
Brooklyn College of the City University of New York
Who can join
Adults 55 to 79, female only, with Cardiovascular Disease or Heart Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators will conduct an epidemiological analysis of data from the Women's Health Initiative to investigate the prospective association between chocolate intake and the risk of heart disease and stroke.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Chocolate intake and heart disease and stroke in the Women's Health Initiative: a prospective analysis.
Greenberg JA, Manson JE, Neuhouser ML, Tinker L, et al · · 2018 · cited 9× · PMID 29931040 · DOI 10.1093/ajcn/nqy073
Verify or expand the search:
- PubMed search for NCT03453073
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiovascular Disease
Currently open trials in the same condition.
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07293260 — Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial · Phase 3 · recruiting
- NCT07497932 — Nutritional Effects in Cardiovascular Surgery · NA · recruiting
- NCT06625073 — Randomized Trial of SGLT2i in Heart Transplant Recipients · Phase 4 · recruiting
- NCT06485700 — Peers and Technology for Adherence, Access, Accountability, and Analytics (PT4A) · NA · recruiting
Other Brooklyn College of the City University of New York trials
Trials by the same sponsor.
- NCT04749719 — At Home Brain Stimulation Studies of Memory and Memory Awareness · NA · unknown
- NCT04026633 — Attitudes & College Experiences · NA · completed
- NCT03693729 — Effects of Brain-stimulation on Metamemory Monitoring and Control · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03453073 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brooklyn College of the City University of New York
- Last refreshed: 6 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03453073.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing